⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for btk intolerant

Every month we try and update this database with for btk intolerant cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHLNCT03740529
Chronic Lymphoc...
Waldenstrom Mac...
Mantle Cell Lym...
Marginal Zone L...
B-cell Lymphoma
Small Lymphocyt...
Pirtobrutinib
Venetoclax
Rituximab
18 Years - Eli Lilly and Company
A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)NCT03162536
Lymphoma, B-Cel...
Small Lymphocyt...
Chronic Lymphoc...
Waldenstrom Mac...
Mantle Cell Lym...
Diffuse Large B...
Richter's Trans...
Follicular Lymp...
Marginal Zone L...
Nemtabrutinib
18 Years - ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)NCT03162536
Lymphoma, B-Cel...
Small Lymphocyt...
Chronic Lymphoc...
Waldenstrom Mac...
Mantle Cell Lym...
Diffuse Large B...
Richter's Trans...
Follicular Lymp...
Marginal Zone L...
Nemtabrutinib
18 Years - ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHLNCT03740529
Chronic Lymphoc...
Waldenstrom Mac...
Mantle Cell Lym...
Marginal Zone L...
B-cell Lymphoma
Small Lymphocyt...
Pirtobrutinib
Venetoclax
Rituximab
18 Years - Eli Lilly and Company
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: